Savant Capital LLC grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 4.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,673 shares of the company’s stock after purchasing an additional 146 shares during the quarter. Savant Capital LLC’s holdings in HCA Healthcare were worth $1,102,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of HCA. FMR LLC increased its holdings in HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Meritage Group LP acquired a new position in shares of HCA Healthcare during the third quarter valued at about $150,548,000. Canoe Financial LP grew its stake in shares of HCA Healthcare by 226,952.9% in the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock valued at $69,513,000 after buying an additional 231,492 shares during the period. Holocene Advisors LP boosted its holdings in HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after acquiring an additional 208,015 shares in the last quarter. Finally, Nordea Investment Management AB increased its holdings in shares of HCA Healthcare by 29.7% during the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after acquiring an additional 193,075 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
HCA has been the subject of a number of analyst reports. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Royal Bank of Canada dropped their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. TD Cowen dropped their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, Oppenheimer increased their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $385.67.
HCA Healthcare Stock Down 1.8 %
HCA Healthcare stock opened at $316.18 on Friday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm has a 50 day simple moving average of $313.30 and a 200 day simple moving average of $352.55. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $80.09 billion, a price-to-earnings ratio of 14.39, a P/E/G ratio of 1.11 and a beta of 1.64.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the firm posted $5.90 earnings per share. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 13.11%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
- Five stocks we like better than HCA Healthcare
- What is a Low P/E Ratio and What Does it Tell Investors?
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Pros And Cons Of Monthly Dividend Stocks
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Trading Halts Explained
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.